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Major insulin gene transcription factors, such as PDX-1 or NeuroD1, have equally important roles in pancreatic development and the
differentiation of pancreatic endocrine cells. Previously, we identified and cloned another critical insulin gene transcription factor MafA
(RIPE3b1) and reported that other Maf factors were expressed in pancreatic endocrine cells. Maf factors are important regulators of cellular
differentiation; to understand their role in differentiation of pancreatic endocrine cells, we analyzed the expression pattern of large-Maf factors in
the pancreas of embryonic and adult mice. Ectopically expressed large-Maf factors, MafA, MafB, or cMaf, induced expression from insulin and
glucagon reporter constructs, demonstrating a redundancy in their function. Yet in adult pancreas, cMaf was expressed in both α- and β-cells, and
MafA and MafB showed selective expression in the β- and α-cells, respectively. Interestingly, during embryonic development, a significant
proportion of MafB-expressing cells also expressed insulin. In embryos, MafB is expressed before MafA, and our results suggest that the
differentiation of β-cells proceeds through a MafB+ MafA− Ins+ intermediate cell to MafB− MafA+ Ins+ cells. Furthermore, the MafB to MafA
transition follows induction of PDX-1 expression (Pdx-1high) in MafB+ Ins+ cells. We suggest that MafB may have a dual role in regulating
embryonic differentiation of both β- and α-cells while MafA may regulate replication/survival and function of β-cells after birth. Thus, this
redundancy in the function and expression of the large-Maf factors may explain the normal islet morphology observed in the MafA knockout mice
at birth.
© 2006 Elsevier Inc. All rights reserved.Keywords: MafA; MafB; Maf factors; Insulin gene transcription factor; Pancreatic development; Endocrine differentiation; Pancreatic isletsIntroduction
Transcription factors binding to three conserved insulin
enhancer elements, A3 (Ohlsson et al., 1991; Boam and
Docherty, 1989), RIPE3b/C1-A2 (Sharma and Stein, 1994;
Shieh and Tsai, 1991), and E1 (Crowe and Tsai, 1989; Karlsson
et al., 1987) are major regulators of insulin gene expression. The
loss of PDX-1, the A3 binding factor, results in mice that are
apancreatic (Jonsson et al., 1994; Offield et al., 1996), whereas
mice homozygous null for NeuroD1, which binds to the E1☆ Maf factors are important for pancreatic differentiation.
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doi:10.1016/j.ydbio.2006.02.028element, have a striking reduction in the number of insulin-
producing β-cells (Naya et al., 1997). These observations
underscore the importance of insulin gene transcription factors
in the development and differentiation of pancreatic endocrine
cells. We have identified and cloned MafA, a member of the
large-Maf family of basic leucine zipper (bZIP) transcription
factors, as the β-cell specific factor binding to the RIPE3b/C1-
A2 element (Maf Response element or MARE) (Olbrot et al.,
2002). RIPE3b1/MafA is a glucose-responsive factor expressed
in insulin-producing cells (Sharma and Stein, 1994; Olbrot et
al., 2002; Matsuoka et al., 2003; Kataoka et al., 2002).
The Maf family of transcription factors are important
regulators of differentiation and regulate processes such as
hematopoiesis, lens differentiation, and segmentation of hind-
brain (Blank and Andrews 1997; Reza and Yasuda 2004; Ogino
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al., 1999; Kawauchi et al., 1999; Ring et al., 2000). In the lens,
Maf factors regulate expression of the major lens-specific
protein crystallins (Ogino and Yasuda, 1998). Expression of
avian MafA/L-Maf in neuroectodermal cells triggered lens
differentiation program (Ogino and Yasuda, 1998), while the
absence of cMaf prevented lens formation and the expression of
crystallin genes (Kawauchi et al., 1999; Kim et al., 1999).
Hence, it was surprising that the loss of MafA did not affect
embryonic pancreatic development (Zhang et al., 2005a).
However, after birth, the loss of MafA resulted in reduced
proportion of β-cells in islets and impaired glucose tolerance,
demonstrating the role of MafA in regulating β-cell replication/
survival and function. In addition to MafA, pancreatic endocrine
cells express other large-Maf family members (Olbrot et al.,
2002; Matsuoka et al., 2003; Kataoka et al., 2004). Since all Maf
family members recognize the consensus MARE element, cells
expressing multiple Maf family members will have competition
to regulate MARE-dependent gene expression. Thus, to
understand the role of Maf factors in the differentiation of
pancreatic endocrine cells, it is essential to determine the
temporal and spatial expression patterns of these factors.
In this study, we demonstrate that in adult mice MafA and
MafB are preferentially expressed in pancreatic β- and α-cells,
respectively. Similarly, at E15.5, MafA and MafB expression
was observed in the insulin- and glucagon-expressing cells.
However, MafB was also expressed in nearly 90% of insulin-
producing cells. The ability of MafB+ cells to express insulin
was associated with Nkx6.1 expression, while MafB+ Nkx6.1−
cells expressed glucagon. Our results demonstrate a gradual
shift in expression from MafB+ insulin+ to MafA+ insulin+ cells
during fetal development, which followed the enhanced PDX-1
expression in insulin+ cells. We suggest that this switch from
MafB+ to MafA+ cells is not essential for generation of insulin+
cells but may play a role in β-cell replication/survival and
function. These results provide an explanation for the lack of
effect on the embryonic development of pancreatic islets in
MafA knockout mice.
Material and methods
Construction of expression vectors
Expression vectors were constructed by conventional molecular biology
techniques. The insulin luciferase reporter constructs −238 WT LUC and its
derivatives mutant 110–09m LUC have been described previously (Harrington
and Sharma, 2001). The glucagon luciferase reporter construct GLU LUC (Lee
et al., 1992) was obtained from Dr. Dan Drucker (Toronto, Canada). The
glucagon promoter from GLU LUC was cloned into multiple cloning sites
(MCS) of pEGFP (Clontech, Palo Alto, CA) to generate GLU GFP. The
expression vectors pcDNAMafA and ΔN-hMafA have been described
previously (Olbrot et al., 2002). Mouse full-length MafB cDNA clone in
pCMV-Sport6 was purchased from ATCC (Manassas, VA). cMaf cDNA from
pCIcMaf (Dr. I-C Ho, BWH, Boston) was cloned into MCS of pcDNA3.1
(Clontech, Palo Alto, CA) to generate pcDNA cMaf.
Mice and immunostaining
The day of vaginal-plug discovery was designated as E0.5 of C57BL/6 mice.
Animals were anesthetized with intraperitoneal injection of Pentobarbitol(50 mg/kg) and dissected. All animal protocols were approved by the Animal
Care Committee of the Joslin Diabetes Center. Pancreata were excised, fixed in
4% paraformaldehyde, embedded in paraffin, and immunostained as described
previously (Laybutt et al., 2002). Antigen retrieval consisted of heating de-
paraffinized tissue sections three times for 5 min each with 0.01 M citrate buffer
in a microwave oven, followed by 20 min cool-down period before proceeding
to the next step. The primary antibodies were guinea pig anti-insulin (Linco);
guinea pig anti-glucagon (Linco); monoclonal anti-synaptophysin (Chemicon);
mouse monoclonal anti-Ki-67 (BD Pharmingen); rabbit anti-Nkx6.1 (provided
by P. Serup); goat anti-PDX-1 (provided by C. Wright); rabbit anti-MafB
(Bethyl); rabbit anti-cMaf (Bethyl); and rabbit anti-Pax6 (Covance). Our rabbit
anti-MafA antibody was raised against the 329 to 347 carboxy-terminal amino
acids of mouse MafA (ProSci, Poway, CA). The specificity of this antibody was
confirmed using its blocking peptide in immunohistochemistry and Western
blotting; the preimmune sera gave no staining at the same concentrations used in
these experiments. Secondary antibodies for immunofluorescence were FITC-
or Texas red-conjugated anti-rabbit, anti-mouse, or anti-guinea pig IgG (Jackson
ImmunoResearch). For amplification, biotinylated anti-rabbit, anti-mouse, or
anti-goat IgG antibodies (1:400, Jackson Immunoresearch) were used followed
by streptavidin-conjugated Texas red (1:400, Jackson Immunoresearch) or
streptavidin-conjugated Alexa fluor 488 (1:400, Molecular Probes). Nuclear
counterstaining was achieved by DAPI mounting medium (Vector). The
immunostaining shown in each figure was derived from several replicates of at
least 5 sections from 3 different mice/embryos. At least 3 different pancreases
were counted for quantitative results. Confocal images were taken on Zeiss
LSM410 (Zeiss, Thornwood, NY); quantitations were performed using NIH
Image J.
Cell culture and immunocytochemistry
HeLa cells were cultured in the Dulbecco's modified Eagle's medium
supplemented with 10% (w/v) FBS, 100 U/ml penicillin, and 100 μg/ml
streptomycin at 37°C under 5% CO2. Cells were transfected with the various
expression plasmids and 1 μg of GLU GFP reporter constructs using
Lipofectamine (Invitrogen, CA). Forty-eight hours after transfection, cells
were fixed with 4% (w/v) paraformaldehyde for 15 min, permeabilized with
0.25% (w/v) Triton X-100 in PBS for 15 min, and immunostained as described
previously (Nishimura et al., 2002). After blocking with PBS containing 10%
(w/v) BSA for 30 min, cells were incubated overnight with the primary antibody
in PBS containing 3% (w/v) BSA, washed with PBS, and incubated with
secondary antibody in PBS containing 3% (w/v) BSA for 1 h, followed by
washing with PBS and mounting.
In situ hybridization
Fresh frozen slides were fixed in 10% buffered formalin (Fisher) for 20 min
at − 20°C. cMaf sense and antisense probes were diluted to 1 ng/μl and incubate
overnight in a humidity chamber at 65°C. Next, slides were washed for
4×30 min in 1× Sodium Chloride-Sodium Citrate (SSC) (Sigma) and then for
1×30 min in Maleaic Acid Buffer w/tween (MABT). Primary Alkaline-
Phosphatase-DIG-antibody (Roche, 1:1000) was added, incubated overnight at
4°C. Staining was developed using BM Purple (Roche) for up to 48 h (4°C
during over-night incubation and RT during daytime). Image of stained section
was taken on Olympus BH2 light microscope. Immediately following in situ
hybridization, slides were washed twice with PBS and incubated with guinea
pig-anti-insulin (1:200) and rabbit-anti-glucagon (1:1000) antibodies for 2 h at
RT. Secondary antibodies donkey-anti-guinea pig-Texas Red and donkey-anti-
rabbit-FITC (Vector Labs, 1:200) were used for 1 h at RT, Confocal images were
taken on Zeiss LSM410 (Zeiss, Thornwood, NY).
Luciferase assays
HeLa cells were transfected with the indicated amount of reporter
constructs of −238 WT LUC, 110–09m LUC, or GLU LUC and with 1 μg of
pSVβ-gal plasmid (Promega, Madison, WI). Whole cell extracts were
prepared and luciferase activity was measured as previously described
(Nishimura et al., 2005).
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Total RNA was extracted from MIN-6 or α-TC 1.6 cells and reverse-
transcribed to cDNA, which was amplified by PCR with appropriate oligonucle-
otide primers as previously described (Olbrot et al., 2002). The results were
confirmed from at least three independent samples. The following oligonucleo-
tides were used for primers: cMaf3′ppT, 5′CTTGTGAGTTTTGGCCTTAT-
GATG3′; cMaf3′ppB, 5′GCTCTGGGGTTGTACTTTTTCTGT3′; MafA3′
ppT, 5 ′TTTCCTCGGCAGCGTCCACTTGTA3 ′ ; Ma fA3 ′ppB ,
5′GGGGGTTCCTCCGGGTTTTCTAAT3′, MafB3′ppT, 5′CTGCG-
CCCCTAGCCCTGGACTC3′; MafB3′ppB, 5′GGCGGCCCTGGCACTCACAQ
AA3′.
Western blot
Forty micrograms of nuclear extracts from indicated cell lines was run on
10% SDS-PAGE and transferred to PVDF membranes, which were subjected to
Western blotting with indicated antibodies and visualized by enhanced
chemiluminescence kit (Amersham Biosciences).Results and discussion
Differential expression of large-Maf factors in pancreatic
endocrine cells
Previously, we reported that, in addition to the MafA,
other large-Maf factors, MafB and cMaf, were expressed in
pancreatic endocrine cells (Olbrot et al., 2002). In a detailed
study, Matsuoka and colleagues (2003) reported that in islets
MafA was expressed in β-cells, MafB in more α- than β-
cells, and cMaf at extremely low levels. Surprisingly,
Kataoka et al. (2004) were unable to demonstrate MafB
expression in α-cells but showed the expression of cMaf in
these cells. Hence, we reexamined the expression profile of
large-Maf factors in pancreatic endocrine cells. RT-PCR was
performed on the RNA isolated from mouse islets, the β-cell
line MIN-6, and the α-cell line α-TC1.6. Since the large-Maf
factors share sequence homology in the coding region, PCR
primers were designed in the unique 3′ untranslated regions.
MafA and MafB expression was mostly restricted to β- and
α-cell lines, respectively, while cMaf was expressed in both
cell lines (Fig. 1A). To determine the relative expression of
these factors, real-time PCR reactions were performed with
the same cDNAs used in Fig. 1A. MafA was expressed at
250-fold higher in β- than in α-cells, while MafB expression
was 450-fold higher in α-cells. Consistent with the results in
Fig. 1A, cMaf expression was similar in both cell lines. This
differential expression of MafA and MafB in pancreatic α-
and β-cells is consistent with the results of Matsuoka et al.
(2003). We determined the expression of large-Maf proteins
in hormone-producing (αTC1.6 and MIN6) and non-hormone
producing (HeLa) cell lines. Protein bands corresponding to
MafA were detected only in the extract from the β-cell line,
while cMaf protein was expressed in both α- and β-cell
lines. Anti-MafA antibody recognized multiple protein bands
(most likely phospho-MafA isoforms) and preincubation of
the antibody with specific peptide prevented this recognition
(Kondo et al., unpublished observation). Anti-MafB antibody
does not work optimally in the Western blot (or the levels ofMafB protein in αTC1.6 are very low), yet results from two
independent samples convincingly showed expression of
MafB in the α-cells (Fig. 1B). Band intensities corres-
ponding to these large-Maf factors were significantly
different in each cell line. Since the affinity of antibodies
for these factors may be different, these intensities may not
reflect true expression levels of these proteins. Even so, the
Western blot analyses are consistent with the RNA
expression pattern (Figs. 1A, B).
In adult pancreas, immunostaining for MafAwas restricted to
the pancreatic β-cells (Figs. 1C, D). Similarly, MafB expression
was highly restricted to α-cell (Figs. 1E, F), and only a few rare
β-cells in the adult pancreas immunostained for MafB. cMaf
was expressed in both α- and β-cells (Figs. 1G, H). These data
differ from the reported MafB expression in nearly a third (37%)
of adult β-cells (Matsuoka et al., 2003). Differences in the
mouse strains and/or antibodies may account for this discrep-
ancy. Immunostaining results are consistent with those from RT-
PCR and Western blot analyses, and together they confirm
differential expression of MafA and MafB in pancreatic β- and
α-cells.
Large-Maf factors activate expression from insulin and
glucagon reporter constructs
Since large-Maf family members are expressed in pancre-
atic β- and α- cells, we examined their effect on regulating
insulin and glucagon gene expression. Rat insulin II promoter:
luciferase reporter constructs (−238 WT LUC) with or without
mutations in the MARE element (Harrington and Sharma,
2001; Olbrot et al., 2002) were transfected into HeLa cells
with MafA, MafB, or cMaf expression plasmids, or
pcDNA3.1 as a control. All three large-Maf factors activated
insulin gene expression from the wild type construct and not
from the construct with the mutated MARE element (Fig. 2A).
To determine if these factors regulate expression by forming
heterodimers, cells were transfected with −238 WT LUC
plasmid and large-Maf expression plasmids with or without
the ΔNMafA plasmid that lacks the N-terminal activation
domain of MafA (Olbrot et al., 2002). Activation of insulin
gene expression mediated by these factors was inhibited by
ΔNMafA (Fig. 2B). As observed for insulin gene expression,
MafA, MafB, and cMaf activated glucagon gene expression,
and this activation was inhibited by ΔNMafA (Fig. 2C). To
assess the ability of Maf factors to activate gene expression at
a single cell level, a glucagon:GFP reporter plasmid was
transfected into HeLa cells with MafA, MafB, cMaf,
ΔNMafA expression plasmids, or pcDNA3.1. Cells singly
transfected with MafA, MafB, or cMaf induced expression
from glucagon reporter construct (as observed by co-
expression of Maf factors and GFP) (Figs. 2D–F) but not in
those cells transfected with ΔNMafA or pcDNA3.1 (Figs. 2G,
H). These results are consistent with the published reports
(Planque et al., 2001; Kataoka et al., 2004; Zhao et al., 2005),
and they demonstrate that MafA, MafB, or cMaf can activate
expression from not only insulin but also glucagon promoter:
reporter constructs.
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pancreatic development
Large-Maf factors have highly conserved C-terminal DNA
binding and protein dimerization domains (Blank and Andrews,
1997). However, homology in the N-terminal activation domain
is less conserved, suggesting possible differences in their
activation potentials and/or downstream targets. Thus, the
expression of different large-Maf factors in the endocrine cells
may differentially affect their function. Additionally, embryonic
expression of these large-Maf factors may have significant
impact on the differentiation of endocrine cell types. The anti-cMaf antibody that in adult pancreatic sections convincingly
demonstrated cMaf expression in both α- and β-cells (Figs. 1G,
H) was found unsuitable for detecting embryonic expression of
this factor. Hence, to detect expression of cMaf during
embryonic development, in situ hybridization was performed
on the frozen pancreatic sections from E17.5 embryos; these
sections were immunostained to detect insulin and glucagon
expressing cells (Fig. 3). Our results demonstrate that as in
pancreatic islets from the adult mice, cMaf was expressed in
both insulin and glucagon producing cells. Unlike cMaf, MafA
is exclusively expressed in β-cells and the expression of MafB
is specific to α-cells in the adult pancreas. Thus, we
hypothesized that MafA is important for the differentiation of
β-cells while MafB has a similar role in the α-cells. Therefore,
we focused our study on examination of spatial and temporal
expression patterns of MafA and MafB during embryonic
development to understand their roles in the pancreas.
Immunostained sections of pancreas from E10.5–P14 were
examined for co-expression of MafA with insulin, and MafB
with glucagon. Glucagon+ cells can be seen soon after
pancreatic specification, and by E10.5 glucagon+ cells are
seen in the pancreatic epithelium (Fig. 4C). Interestingly, cells
in these early glucagon+ clusters express MafB, but occasional
MafB+ cells near these clusters did not express glucagon (Figs.
4C, F). These data suggest that embryonically MafB is
expressed in pancreatic cell types other than glucagon or that
its expression precedes that of glucagon. In contrast to
glucagon+ cells that are easily detected by E10.5, insulin+
cells are rare, and their number increases only after the
secondary transition (around E13.5). At E10.5 and 11.5, neither
insulin+ nor MafA+ cells were found, but the rare insulin+ cells
at E12.5 and E13.5 expressed MafA (Figs. 4G, I). These results
are similar to the report that MafA+ cells can be detected only
from E13.5 (Matsuoka et al., 2004). The apparent discrepancy
of our finding a few insulin+ MafA+ cells at E12.5 and
Matsuoka et al. (2004) could be due simply to the limited
number of insulin+ cells observed in the E12.5 pancreas. By
E15.5, there is a significant increase in the number of insulin+
and glucagon+ cells (Figs. 4J, K). All of the MafA+ cells at thisFig. 1. Large-Maf factors are differentially expressed in pancreatic α- and β-
cells. (A) mRNA expression levels of different Maf factors: cDNAs prepared in
the absence or the presence of reverse transcriptase (RT) from total RNA
isolated from mouse islets, MIN-6 cells, and α-TC1.6 cells, were used for PCR
with the indicated primers. Cyclophilin was used as a control. A representative
gel from at least three independent experiments is shown. The same cDNAs
were used for real-time quantitative PCRwith primers and probes corresponding
to the three large-Maf factors. The relative expression levels were quantitated
using ΔΔCT method with 18S rRNA as a control. (B) Protein expression levels
of different Maf factors: nuclear extract from MIN-6 cells, α-TC1.6 cells, and
HeLa cell lines was used to detect specific Maf factors by Western blot analyses
as described in the Materials and methods. Two independent samples (a and b)
each from αTC1.6 and MIN-6 cell lines were used to confirm the expression of
MafB and cMaf. Asterisks denote non-specific bands. (C) Double immunohis-
tochemical (IHC) detection of MafA, MafB, or cMaf (green) with either insulin
or glucagon (red) in the adult mouse pancreas. Note selective expression of
MafA and MafB in insulin+ and glucagon+, cells respectively, while expression
of cMaf can be detected in both cell types. Insets, higher magnification of
demarcated area. Scale bar = 20 μm.
Fig. 2. MafA, MafB, and cMaf can activate insulin and glucagon expression. (A) Luciferase reporter plasmids (−238 WT LUC or −122.121m LUC) were transfected
into HeLa cells with the indicated expression plasmids (pcDNA3.1, MafA, MafB, or cMaf). Luciferase activity was determined 48 h after transfection. Results are
presented relative to the activity of −238 WT luciferase construct transfected with pcDNA3.1 ± SE (n = 4). (B) Luciferase reporter plasmid (−238 WT LUC) and
indicated expression plasmid were transfected into HeLa cells with or without ΔNMafA plasmid that lacks N-terminal activation domain. Results are presented as in
panel A (n = 3). (C) Glucagon Luciferase reporter plasmid (−2.2 Glucagon LUC; Lee et al., 1992) and indicated expression plasmid were transfected into HeLa cells
with or withoutΔNMafA plasmid. Results are presented as in panel A (n = 3). Rat glucagon: GFP reporter plasmid was transfected into HeLa cells with (D) MafA, (E)
MafB, (F) cMaf, (G) ΔNMafA expression plasmids, or (H) pcDNA3.1. Forty-eight hours after transfection, HeLa cells were immunostained to detect GFP (green),
nuclei (DAPI blue), and Maf factors (Red), using anti-MafA (D and G), MafB (E), cMaf (F), and large-Maf (H) antibodies. Each figure shows combined three-color
image, while the insets show signals from individual color channels. Scale bar = 20 μm.
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insulin+ cell did not express MafA. Interestingly, at E15.5
nearly all (98%) glucagon+ cells expressed MafB, but asignificant number of MafB+ cells did not express glucagon.
MafB is selectively expressed in the α-cells of the adult
pancreatic islets; we determined that MafB expression gradually
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MafB+ glucagon− cells are seen (Figs. 4L–N).
MafB is expressed in the insulin-producing cells during
development
The increased number of MafB+ glucagon− cells around
secondary transition suggests an important role of this factor in
regulating differentiation of other pancreatic cell-type(s). To
determine if the E15.5 MafB+ glucagon− cells were endocrine
cells, pancreatic sections were immunostained to detect MafB
and synaptophysin expression. All MafB+ cells were synapto-
physin+, but not all synaptophysin+ cells expressed MafB (Fig.
5A), suggesting that MafB is expressed in only some endocrine
cells at this stage of development. Since the number of insulin+
cells increases at the secondary transition, we examined if the
MafB+ Glucagon− cells expressed insulin and the MafA+ cells
expressed glucagon. We observed that MafA+ cells did not
express glucagon, while many MafB+ cells were insulin+ (Figs.
5B, C). This was in direct contrast with the highly selective α-
cell expression of MafB in adult islets. Quantitation showed that
all the 137 MafA+ cells co-expressed insulin, while nearly 60%
of MafB+ cells were insulin+ (Fig. 5F). Interestingly, only half
(54%) of the insulin+ cells were MafA+ whereas nearly 90% of
insulin+ cells expressed MafB. These observations demonstrate
that at E15.5 some insulin+ cells express MafB, a significant
proportion express both MafA and MafB, and a minor
population only express MafA.Fig. 3. During embryonic development, cMaf is expressed in both insulin+ and
glucagon+ cells. (A) A light microscope image of E17.5 pancreas following in
situ hybridization shows cMaf expression (dark staining). (B) Confocal image of
the same section stained for insulin (red) and glucagon (green). Panels C–E are
higher magnification images of inset shown in panel A and the corresponding
region from panel B. One insulin- and one glucagon-expressing cell are
numbered in the higher magnification image to clearly show that cMaf is
expressed in both cell types. Scale bar = 20 μm.
Fig. 4. MafA and MafB expression pattern during embryonic development.
Confocal images of immunostained pancreatic sections from indicated
embryonic (E10.5–E15.5) and postnatal days 5, 8, and 14. Sections were
stained with indicated antibodies that recognize transcription factors PDX-1,
MafA or MafB (green), or hormones insulin or glucagon (red) and nuclei (DAPI
blue). Results show that MafB is expressed earlier (E10.5) than MafA (E12.5) in
developing pancreas. MafA expression is restricted to insulin+ cells. At the
earlier time points (E10.5–11.5), the majority of MafB+ cells express glucagon,
and only occasional glucagon−MafB+ cells are seen (arrows in panels C and F),
but around E15.5, there is a significant increase in the number of glucagon−
MafB+ cells. After birth, expression of MafB again becomes restricted to
glucagon+ cells. Scale bar = 20 μm for all images except panels Ja and Ka, where
scale bar = 50 μm.To determine MafA and MafB co-expression with insulin,
we stained thin (3 μm) consecutive sections of E15.5 pancreas
with appropriate antibodies (Figs. 6A, B). Insulin staining in
consecutive sections identified cells that were present in both
Fig. 5. MafB is expressed in insulin-producing cells during embryonic
development. (A) Confocal images of E15.5 pancreas stained for MafB
(green), Synaptophysin (red), and nuclei (DAPI, Blue). All MafB+ cells are
Synaptophysin+, but not all Synaptophysin+ cells are MafB+ (arrow). Images B
and C show E15.5 pancreas stained for MafA (green), glucagon (red), and nuclei
(DAPI, blue), or MafB (green) insulin (red) and nuclei (DAPI, blue),
respectively. Images Bb and Cb show areas marked in images Ba and Ca at
higher magnification. Quantitation is shown as percentage of MafA+(D) or
MafB+(F) cells expressing insulin or the percentage of insulin+ cells expressing
MafA (E) or MafB (G). Results are from at least five independent sections from
three different pancreases. A significant proportion of MafB+ cells express
insulin. MafA is expressed only in the insulin+ cells, but several insulin+ cells do
not express MafA. Scale bar = 50 μm (Ba, Ca), 20 μm (A, Bb, Cb).
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expression in the same cell. This analysis provides novel
information regarding the differentiation of insulin+ cells
during embryonic development: (1) all insulin+ cells expressed
at least MafA or MafB; (2) in insulin+ cells, we can identify all
possible combinations (only MafB, only MafA or both) of
large-Maf factor expression (Figs. 6A, B, and insets). The
observed proportion of these three cell-types was consistent
with the results in Fig. 5. MafB is expressed earlier than the
MafA (Figs. 4 and 5) and becomes restricted to α-cells during
the postnatal period (Fig. 4), and adult insulin+ cells express
MafA (Fig. 1). Furthermore, we found that during different
stages of embryonic development less than 1% of insulin+ cells
(E13.5 none, E15.5, and E18.5 0.6%) are apoptotic as judged
by condensed nuclei visualized with propidium iodide (data
not shown); these data suggest that the majority of insulin+
MafB+ cells at E15.5 survive and give rise to the insulin+ cells
found after birth. We propose a model in which in any given
insulin+ cell MafB expression precedes that of MafA, with a
gradual inhibition in MafB expression in the MafA+ MafB+
insulin+ cells, resulting in the generation of insulin+ MafA+
cells. A future lineage tracing study should provide definitive
proof for such switch. However, this model raises several
important questions, including whether MafB turns on the
expression of insulin and glucagon, that is, is MafB upstream
of these hormones? What regulates the choice of MafB+ cells
to express either insulin or glucagon? What turns on MafA
expression in MafB+ insulin+ cells? Finally, why do insulin+
cells transition from MafB+ to a MafA+ cell-type when both
factors can bind to the insulin MARE and activate insulin gene
expression?
Differential expression of Nkx6.1 in MafB+ cells defines the
cells that express insulin or glucagon
The generation and analysis of MafB knockout mice will
eventually address whether MafB is upstream or downstream of
insulin and glucagon gene expression. However, our results
suggest that MafB is an important differentiation factor for both
α- and β-cells. A significant proportion of insulin+ cells
expressed both MafA and MafB, but glucagon+ cells expressed
only MafB, so we decided to test whether the expression of
Nkx6.1 correlated with the ability of MafB+ cells to express
insulin. The transcription factor Nkx6.1 is critical for the
differentiation of β-cells (Sander et al., 2000), and is required
for the expression of MafA (Matsuoka et al., 2004). In
consecutive sections of E15.5 pancreas, significantly more
cells expressed Nkx6.1 than MafB+ (Figs. 7A, B). As reported
previously (Sander et al., 2000), at this stage, a reasonable
proportion of Nkx6.1+ cells are insulin− (Fig. 7B). We observed
that, at E15.5, the majority of insulin+ cells also expressed
Nkx6.1and MafB (arrow Figs. 7A, B, and insets) but that
MafB+ glucagon+ cells did not express NKX6.1 (closed
triangle, Figs. 7C, D). Importantly, cells that were Nkx6.1+
MafB+ were glucagon− (arrows Figs. 7C, D). Thus, the ability
of MafB-expressing cells to expresses glucagon or insulin
depends on the co-expression of Nkx6.1.Nkx6.1 is upstream of MafA during pancreatic develop-
ment and is important for the differentiation of insulin+
cells. However, Nkx6.1 is not likely to be upstream of
MafB since glucagon+ MafB+ cells do not express Nkx6.1
(glucagon+ Nkx6.1+ cells are extremely rare; Henseleit et
al., 2005). Even so, we cannot rule out the possibility that
Nkx6.1 is upstream of MafB in cells that will turn on
insulin expression. Since a few insulin+ cells can be
detected in Nkx6.1 knockout mice (Henseleit et al., 2005;
Matsuoka et al., 2004), Nkx6.1 may not be essential for the
Fig. 6. Expression of MafA andMafB in the insulin+ cells. Two consecutive sections from E15.5 mouse pancreas stained with the indicated antibodies to detect insulin
(red), nuclei (blue), and either MafA (A) or MafB (B). One can identify all possible combinations of MafA and MafB expression in the insulin+ cells. Cells indicated
with arrows are MafB+ insulin+ but MafA−, cells indicated with the open arrowheads express both MafA and MafB, while cells indicated by filled arrowheads
demonstrate the presence of MafA+ insulin+ MafB− cells. Lower images are higher magnification of the boxed areas in panels A and B; cells are numbered to identify
the same cells in both sections. Total number of MafA and MafB expressing nuclei at E15.5 from five adjacent pairs of sections from three different pancreases (C)
shows over 3-fold higher proportion of MafB+ cells at this stage (P = 0.01). Scale bar = 20 μm.
533W. Nishimura et al. / Developmental Biology 293 (2006) 526–539formation of insulin+ cells. This finding suggests two other
possibilities for differentiation of insulin+ cells: (1) MafB
can initiate differentiation of insulin-expressing cells and
Nkx6.1 is required for the maintenance of insulin
expression and induction of MafA; (2) Nkx6.1 and MafB
together trigger the differentiation of insulin+ cells (we did
observe a few rare MafB+ Nkx6.1+ cells that were
insulin−). Demonstration of MafB expression in the
remaining insulin+ cells in Nkx6.1 knockout mice would
support the first possibility. The absence of insulin+ cells,
even in the presence of Nkx6.1+ cells, in MafB knockout
mice would also be consistent with the first possibility.
However, reduced numbers of insulin+ cells in MafB
knockout mice would support the second. The definitive
answer for the importance of MafB and Nkx6.1 in the
differentiation of insulin+ cells will only come from the
analyses of these knockout mice.
Role of MafA in β-cell replication and maturation
Our results suggest a switch in the expression from MafB
to MafA in insulin+ cells, raising questions such as, what
regulates the switch in the transcription factor expression, and
is it necessary? The MafA knockout mouse study (Zhang et
al., 2005a) would suggest that the switch to MafA is required
for the survival/proliferation and function of β-cells. The loss
of MafA resulted in normal pancreatic morphology at birth,
but after birth a reduction in the proportion of β-cells with
resulting impaired glucose tolerance and diabetes (Zhang et
al., 2005a).
Terminally differentiated β-cells have glucose-induced
insulin secretion whereas fetal and neonatal islets are not yet
glucose-responsive. The MafA knockout study showed Glut2
expression reduced in the knockout animals. Since more fetal
and neonatal insulin+ cells express MafB than in adult mice, thetransition from MafB to MafA expression may initiate the
glucose-responsiveness of insulin+ cells by the selective
induction of glucose transporter Glut2. In E15.5 pancreas
(Fig. 8), Glut2 is expressed in some MafA+, MafB+, or Nkx6.1+
cells. Some of these MafB+ Glut2+ or MafA+ Glut2+ cells also
express insulin. This suggests that the switch from MafB to
MafA may not be needed for the maturation of β-cells, as
judged by the induction of Glut2 expression. The observed
expression of Glut2 in MafB+ or MafA+ cells may reflect
differentiation of these cells from Glut2+ precursors (Pang et al.,
1994). We find that, at E15.5, more MafB+ than MafA+ cells
express Glut2, which is consistent with our hypothesis that
during differentiation of insulin+ cells, MafB is induced first,
followed by the expression of MafA. This would suggest that
the Glut2 expression at E15.5 is a marker of precursor cells
rather than the maturation of β-cells. The lack of a correlation
between MafA and Glut2 expression in insulin+ cells (Fig. 8D)
is not consistent with the observed reduction in the Glut2
expression in MafA null mice (Zhang et al., 2005a). However,
as reported in other animal models (Thorens et al., 1990),
reduction in the Glut2 expression could result from the
hyperglycemia in these mice. Thus, our results demonstrate
that the switch from MafB to MafA at E15.5 is not required for
the induction of Glut2 expression but that MafA expression may
turn-on additional genes critical for the function of adult β-cells.
The loss of MafA results in a reduced proportion of β-cells
after birth, suggesting a possible role of the transition from
MafB to MafA in the replication/survival of β-cells. To test
for a role of these factors in β-cell replication, the co-
expression of cell cycle marker Ki67 with MafA and MafB
factors was examined in E15.5 and P14 pancreas. Consistent
with previous observations that newly differentiated endocrine
cells do not proliferate, we found in E15.5 mice that nearly
25% of the Nkx6.1+ cells are in the cell cycle (Ki67+) but
none of the MafA+ cells and only a rare MafB+ cell
Fig. 7. MafB+ and insulin+ cells express NKX6.1 but MafB+ glucagon+ cells are NKX6.1−. Consecutive sections A and B show cells expressing insulin (red), nuclei
(blue), and either MafB or Nkx6.1 (green). Arrows denote cells that are present in both sections and express both Nkx6.1 and MafB. All of the insulin+ cells are
Nkx6.1+, but not all Nkx6.1+ cells were insulin+. Higher magnification image of areas marked in panels D and E is shown at the bottom. Total number of nuclei
expressing the indicated factor at E15.5 from five adjacent pairs of sections from three different pancreases (C). Significantly more (50% P = 0.001) Nkx6.1+ cells are
seen at E15.5 than MafB+ cells. Panels D and E represent consecutive sections stained to detect glucagon (red), nuclei (blue), and MafB or Nkx6.1 (green). The
arrowheads denote glucagon+ MafB+ cells that are Nk6.1−, while arrows indicate MafB+ Nkx6.1+ cells that are glucagon−. Scale bar = 20 μm.
Fig. 8. MafB to MafA transition is not essential for Glut2 expression. Triple IHC detection of (A) Nkx6.1, (B) MafA, or (C) MafB expression (green) with Glut2 (red)
and nuclei (DAPI blue) shows that at E15.5 only some of the transcription factor expressing cells are Glut2+ (arrow). Staining in panel E shows that some MafB+
insulin+ cells are Glut2+ MafA− (arrowhead), thus demonstrating that MafA expression in the insulin+ cells is not essential for the expression of Glut2 at this stage of
development. Scale bar = 20 μm.
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9A–D). However, from shortly before birth up to 2 weeks
after birth, the replication rate of endocrine cells is significant
(Figs. 9E–H). At P14, the proportion of Ki67+ Nkx6.1+ cells
was reduced significantly (5.3%) and was comparable to the
proportion of Ki67+ MafA+ cells (7.7%), possibly reflectingFig. 9. MafB expression does not inhibit replication of insulin+ cells. Mouse pancreat
(green) with Ki67 (red) and DAPI (blue). Insets show higher magnification of de
transcription factor. (D) Quantitation of Ki67+ cells showed that nearly 25% of Nkx6
Ki67 at this stage. Expression of NKX6.1 (E), MafA (F), or MafB (G) (green) in Ki6
(blue), and either MafA (H) or MafB (I) in green. (J) Quantitation of at least five ind
similar levels of Ki67+, Nkx6.1+, and MafA+ cells, while a higher proportion of MafB
the pancreatic islet. Scale bar = 20 μm.the restriction of Nkx6.1 to the β-cells. Nearly 17% of MafB+
cells expressed Ki67, showing that MafB expression does not
impede replication. It is important to note that the increased
replication rate of the MafA+ and MafB+ cells after birth
accompanies the change from co-expression to single
expression of these factors. Even though the majority ofic sections at E15.5 were stained to detect (A) NKX6.1, (B) MafA, or (C) MafB
marcated areas. Arrows indicate cells expressing both Ki67 and the indicated
.1 cells are in cell cycle, while MafA and MafB expressing cells do not express
7 (red) positive cells in pancreas at P14. Panels H and I show Ki67 (red), insulin
ependent sections from three different mice for each transcription factor shows
+ cells express Ki67. Panel I shows insulin+ MafB+ cell expressing Ki67 at P14 in
Fig. 10. Pax6 expression precedes MafA expression. Consecutive sections from E15.5 pancreas stained to detect MafA (A) and Pax6 (B) show that all insulin+ cells
express Pax6 but not MafA. Arrows in panel A indicate MafA+ cells. Several insulin+ Pax6+ cells that are MafA− are shown at the higher magnification. Total number
of nuclei expressing the indicated factor at E15.5 from five adjacent pairs of sections from three different pancreases (C). Nearly 6-fold more nuclei were Pax6+ than
MafA+ at this stage of development (P = 0.004).
Fig. 11. Induction of PDX-1high in the insulin+ cells precedes the switch in expression from MafB+ to MafA+. Co-expression of MafA (A) and PDX-1high (B) in the
insulin+ cells was determined by staining consecutive sections. Total number of nuclei expressing the indicated factor at E15.5 from five adjacent pairs of images from
three different pancreases (C, F). At E15.5, nearly 66% more nuclei were expressing high level of PDX-1high than MafA (P = 0.006), yet at this stage not all insulin+
cells were PDX-1high. Arrows indicate PDX-1high cells that were MafA−, and arrowheads indicate insulin+ cells that are MafA− PDX-1low. Panels D and E show that
some insulin+ MafB+ cells were PDX-1low (arrows), while others were PDX-1high. There are nearly 2-fold more MafB+ than the Pdx-1high cells at this stage (F,
P = 0.01). These results show that PDX-1high expression is induced after MafB but before MafA expression.
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few Ki67+ MafB+ insulin+ cells. Thus, our results suggest
that the presence of MafB in the insulin+ cell does not
prevent their replication. However, the paucity of MafB+
glucagon− cells at this stage and the fact that some MafB+
insulin+ cells may already express MafA preclude our being
able to conclude whether the expression of MafB in the
insulin+ cells impairs but does not prevent β-cell replication.
PDX-1 expression precedes induction of MafA in MafB+
insulin+ cells
Transcription factor Nkx6.1 is upstream of MafA (Matsuoka
et al., 2004), but at E15.5 not all Nkx6.1+ insulin+ cells express
MafA with a significant proportion being MafB+ (Fig. 7 and
data not shown), suggesting that signals in addition to NKx6.1
are needed to trigger MafA expression. Transcription factors
PDX-1, HB9, and Nkx2.2 are widely expressed in the early
pancreatic epithelium. With time, their expression gradually
becomes restricted while others, such as Pax4, Pax6, and
NeuroD1, are expressed in the endocrine progenitors, following
Ngn3 expression. Recent studies demonstrate that the tran-
scription factors Nkx2.2 and Pax4 work in parallel to enable β-
cell differentiation (Prado et al., 2004; Wang et al., 2004).
Nkx2.2, its downstream target Pax6, and Pax4 enhance
expression of PDX-1, HB9, and Nkx6.1, which are required
for the maturation of β-cells. Interestingly, in a recent review,
Sosa-Pineda (2004) reports that loss of Pax4 inhibits MafA
expression, suggesting a possible link between MafA expres-
sion and β-cell maturation. Unfortunately, there are no good
antibodies to monitor Pax4 expression during pancreatic
development and hence we cannot determine the role of thisFig. 12. Model of Maf factor transition and the differentiation of insulin+ cells. En
insulin+ phenotype, while precursors expressing MafB alone follow a pathway to g
are Pax6+, PDX-1low, and MafA−. Subsequently, there is induction of PDX-1high
Towards the later stages of embryonic development and the early neonatal perio
insulin+ MafA+ MafB− cells.factor in MafB to MafA switch. A recent lineage-tracing study
demonstrates a role for Pax6 in the expression of terminal
differentiation markers such as insulin and Glut2 (Ashery-
Padan et al., 2004). Since the MafB to MafA switch may
regulate terminal differentiation, we analyzed the role of
transcription factors PDX-1 and Pax6 in inducing MafA
expression.
During lens development in the chicken, Pax6 is required
for the expression of MafA/L-Maf, thus placing Pax6
upstream of MafA (Reza and Yasuda, 2004; Reza et al.,
2002). To determine if Pax6 is upstream of MafA expression
in the insulin+ cells, consecutive sections were stained for
MafA-insulin and Pax6-insulin. Pax6 is expressed in all
endocrine cells, so at E15.5, all insulin+ and several insulin−
cells expressed it (Fig. 10B). MafA is expressed only in some
insulin+ cells (Fig. 10A), so several Pax6+ insulin+ cells were
MafA+ (indicated by arrows) while some were MafA−
(shown in inset). Pax6 is expressed in all insulin+ cells, so
we can conclude that Pax6 is upstream of MafA during β-cell
differentiation but cannot determine if Pax6 is required for
switching the expression from MafB to MafA.
To assess the role of PDX-1 in triggering MafA expression in
MafB+ cells, consecutive sections from E15.5 pancreases were
stained for insulin and MafA, MafB, or PDX-1 (Figs. 11A–D).
As previously reported (Oster et al., 1998; Jensen et al., 2000),
PDX-1 expression can be varied at this stage with most PDX-
1high cells being insulin+ while few PDX-1low cells expressed
insulin+. All MafA+ cells were PDX-1high, and only a few
insulin+ PDX-1high cells did not express MafA (insets Figs.
11A, B). Since insulin+ cells express at least one of the two
large-Maf factors, Pdx-1low insulin+ MafA− cells and PDX-
1high insulin+ MafA− cells must express MafB. Figs. 11C and Ddocrine precursors expressing both MafB and Nkx6.1 differentiate towards an
lucagon-expressing cells. In addition to MafB and Nkx6.1, initial insulin+ cells
expression, which is followed by expression of MafA in the insulin+ cells.
d, insulin+ MafA+ MafB+ cells can be seen and these then differentiate into
538 W. Nishimura et al. / Developmental Biology 293 (2006) 526–539confirm these predictions and demonstrate that, at E15.5,
insulin+ MafB+ cells could express either PDX-1high or PDX-
1low but that MafA is expressed only in cells with high levels of
PDX-1. These data suggest that PDX-1 is enhanced prior to the
expression of MafA but after MafB expression and so may play
a role in turning on MafA in MafB+ cells. MafA can regulate
PDX-1 expression in adult islets (Samaras et al., 2003).
However, the presence of PDX-1high MafA− insulin+ cells at
secondary transition stage suggests that MafA does not activate
PDX-1 expression at this developmental stage. Our results
demonstrating that increased expression of PDX-1 in insulin+
cells at secondary transition occurs before MafA induction
suggest that the MafB to MafA switch proceeds through a PDX-
1high intermediate stage. Analysis of endocrine-cell specific
PDX-1 knockout mice (PDX-1PBCreER™; Zhang et al., 2005b)
could determine the role of PDX-1 in this switch.
In summary, we have shown that the differentiation of β-
cells (insulin+ MafA+) from pancreatic endocrine precursors
goes through an intermediate stage of insulin+ MafB+ that after
the induction of PDX-1 gives rise to insulin+ MafB+ MafA+
cells, which eventually become insulin+ MafA+ cells (Fig. 12).
Since insulin+ MafB+ cells are detected first and can be seen
even after birth, our results suggest that MafA expression is
not necessary for the formation of insulin+ cells during
embryonic development and that MafB is sufficient for the
formation of insulin+ cells. This observation provides an
explanation for the normal looking pancreatic islets in MafA
knockout mice at postnatal day 1(Zhang et al., 2005a). Our
data provide strong evidence for a role of MafB in regulating
differentiation of both α- and β-cells, with the possibility that
MafB, either independently or together with Nkx6.1, triggers
insulin expression. Analyses of MafB and Nkx6.1 knockout
mice for the expression of MafA, MafB, and insulin should
further define the role of these factors in triggering insulin
expression.
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